Valeant Pharmaceuticals Intl (VRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRX | CTLT | STVN | ||
| Company | Valeant Pharmaceuticals Intl | Catalent Inc | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 24.15 | 55.88 | 27.98 | ||
| High | 24.43 | 56.11 | 28.17 | ||
| Low | 23.36 | 55.75 | 27.35 | ||
| Last | 23.40 | 55.92 | 27.54 | ||
| Change | -0.83 | +0.12 | +0.02 | ||
| % Change | -3.43% | +0.22% | +0.07% | ||
| Volume | 6,569,300 | 2,846,300 | 335,500 | ||
| 20-Day Average Volume | 6,685,200 | 1,688,135 | 347,865 | ||
| Previous Close | 24.23 | 55.80 | 27.52 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.73 | 56.30 | 28.78 | ||
| 20-Day Raw Stochastic | 18.46% | 28.09% | 16.43% | ||
| 20-Day Relative Strength | 52.09% | 50.06% | 41.81% | ||
| Weighted Alpha | +35.20 | +36.52 | -3.35 | ||
| Today's Opinion | N/A | 40% Buy | 56% Sell | ||
| Previous Opinion | N/A | 40% Buy | 56% Sell | ||
| Last Month's Opinion | N/A | 96% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.92% since 07/06/18 | +0.79% since 04/19/24 | +3.03% since 04/19/24 | ||
| Low | 23.02 on 07/09/18 | 55.60 on 04/22/24 | 26.47 on 04/25/24 | ||
| High | 24.43 on 07/13/18 | 56.32 on 04/22/24 | 28.17 on 04/26/24 | ||
| 1-Month | |||||
| %Chg | -12.88% since 06/13/18 | -0.60% since 03/26/24 | -13.37% since 03/26/24 | ||
| Low | 22.56 on 06/28/18 | 55.42 on 04/19/24 | 26.47 on 04/25/24 | ||
| High | 27.25 on 06/14/18 | 57.20 on 04/11/24 | 33.49 on 03/27/24 | ||
| 3-Month | |||||
| %Chg | +36.44% since 04/13/18 | +7.06% since 01/26/24 | -13.18% since 01/26/24 | ||
| Low | 16.76 on 04/16/18 | 51.54 on 01/31/24 | 25.52 on 03/21/24 | ||
| High | 27.79 on 06/13/18 | 60.20 on 02/05/24 | 34.73 on 02/07/24 | ||
| 6-Month | |||||
| %Chg | -1.85% since 01/12/18 | +42.40% since 10/26/23 | -4.94% since 10/26/23 | ||
| Low | 14.44 on 03/02/18 | 31.80 on 11/01/23 | 23.00 on 11/01/23 | ||
| High | 27.79 on 06/13/18 | 60.20 on 02/05/24 | 34.73 on 02/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,159,814 | 10,120,065 | 8,139,172 | ||
| Shares Outstanding, K | 348,710 | 180,974 | 295,540 | ||
| Annual Sales | 8,724,000,000 | 4,263,000,000 | 1,174,680,000 | ||
| Annual Net Income | 2,404,000,000 | -256,000,000 | 157,620,000 | ||
| Last Quarter Sales | 1,995,000,000 | 1,024,000,000 | 345,420,000 | ||
| Last Quarter Net Income | -2,693,000,000 | -206,000,000 | 48,700,000 | ||
| 60-Month Beta | -0.38 | 1.20 | 0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.89 on 05/08/18 | -0.24 on 02/09/24 | 0.19 on 03/07/24 | ||
| Latest Earnings Date | 08/14/18 | 06/10/24 | 05/09/24 | ||
| Most Recent Dividend | 1.000 on 11/10/10 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 6.12 | 0.00 | 44.39 | ||